Form 8-K - Current report:
SEC Accession No. 0001104659-26-091099
Filing Date
2026-08-05
Accepted
2026-08-05 16:11:23
Documents
63
Period of Report
2026-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2622272d1_8k.htm   iXBRL 8-K 29119
2 EXHIBIT 99.1 tm2622272d1_ex99-1.htm EX-99.1 81303
3 EXHIBIT 99.2 tm2622272d1_ex99-2.htm EX-99.2 76756
7 GRAPHIC tm2622272d1_ex99-2img001.jpg GRAPHIC 113418
8 GRAPHIC tm2622272d1_ex99-2img002.jpg GRAPHIC 253352
9 GRAPHIC tm2622272d1_ex99-2img003.jpg GRAPHIC 134206
10 GRAPHIC tm2622272d1_ex99-2img004.jpg GRAPHIC 133148
11 GRAPHIC tm2622272d1_ex99-2img005.jpg GRAPHIC 154598
12 GRAPHIC tm2622272d1_ex99-2img006.jpg GRAPHIC 146802
13 GRAPHIC tm2622272d1_ex99-2img007.jpg GRAPHIC 102945
14 GRAPHIC tm2622272d1_ex99-2img008.jpg GRAPHIC 132219
15 GRAPHIC tm2622272d1_ex99-2img009.jpg GRAPHIC 138309
16 GRAPHIC tm2622272d1_ex99-2img010.jpg GRAPHIC 107947
17 GRAPHIC tm2622272d1_ex99-2img011.jpg GRAPHIC 112498
18 GRAPHIC tm2622272d1_ex99-2img012.jpg GRAPHIC 168060
19 GRAPHIC tm2622272d1_ex99-2img013.jpg GRAPHIC 143231
20 GRAPHIC tm2622272d1_ex99-2img014.jpg GRAPHIC 118691
21 GRAPHIC tm2622272d1_ex99-2img015.jpg GRAPHIC 141149
22 GRAPHIC tm2622272d1_ex99-2img016.jpg GRAPHIC 121797
23 GRAPHIC tm2622272d1_ex99-2img017.jpg GRAPHIC 123004
24 GRAPHIC tm2622272d1_ex99-2img018.jpg GRAPHIC 118951
25 GRAPHIC tm2622272d1_ex99-2img019.jpg GRAPHIC 119193
26 GRAPHIC tm2622272d1_ex99-2img020.jpg GRAPHIC 143751
27 GRAPHIC tm2622272d1_ex99-2img021.jpg GRAPHIC 114451
28 GRAPHIC tm2622272d1_ex99-2img022.jpg GRAPHIC 106603
29 GRAPHIC tm2622272d1_ex99-2img023.jpg GRAPHIC 106265
30 GRAPHIC tm2622272d1_ex99-2img024.jpg GRAPHIC 100240
31 GRAPHIC tm2622272d1_ex99-2img025.jpg GRAPHIC 136171
32 GRAPHIC tm2622272d1_ex99-2img026.jpg GRAPHIC 78972
33 GRAPHIC tm2622272d1_ex99-2img027.jpg GRAPHIC 106927
34 GRAPHIC tm2622272d1_ex99-2img028.jpg GRAPHIC 95854
35 GRAPHIC tm2622272d1_ex99-2img029.jpg GRAPHIC 91207
36 GRAPHIC tm2622272d1_ex99-2img030.jpg GRAPHIC 128973
37 GRAPHIC tm2622272d1_ex99-2img031.jpg GRAPHIC 56744
38 GRAPHIC tm2622272d1_ex99-2img032.jpg GRAPHIC 111972
39 GRAPHIC tm2622272d1_ex99-2img033.jpg GRAPHIC 126102
40 GRAPHIC tm2622272d1_ex99-2img034.jpg GRAPHIC 138803
41 GRAPHIC tm2622272d1_ex99-2img035.jpg GRAPHIC 120438
42 GRAPHIC tm2622272d1_ex99-2img036.jpg GRAPHIC 112549
43 GRAPHIC tm2622272d1_ex99-2img037.jpg GRAPHIC 118994
44 GRAPHIC tm2622272d1_ex99-2img038.jpg GRAPHIC 143689
45 GRAPHIC tm2622272d1_ex99-2img039.jpg GRAPHIC 109050
46 GRAPHIC tm2622272d1_ex99-2img040.jpg GRAPHIC 100885
47 GRAPHIC tm2622272d1_ex99-2img041.jpg GRAPHIC 101243
48 GRAPHIC tm2622272d1_ex99-2img042.jpg GRAPHIC 143429
49 GRAPHIC tm2622272d1_ex99-2img043.jpg GRAPHIC 88965
50 GRAPHIC tm2622272d1_ex99-2img044.jpg GRAPHIC 82995
51 GRAPHIC tm2622272d1_ex99-2img045.jpg GRAPHIC 113408
52 GRAPHIC tm2622272d1_ex99-2img046.jpg GRAPHIC 111081
53 GRAPHIC tm2622272d1_ex99-2img047.jpg GRAPHIC 76188
54 GRAPHIC tm2622272d1_ex99-2img048.jpg GRAPHIC 145801
55 GRAPHIC tm2622272d1_ex99-2img049.jpg GRAPHIC 105906
56 GRAPHIC tm2622272d1_ex99-1img01.jpg GRAPHIC 5410
  Complete submission text file 0001104659-26-091099.txt   8452992

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ptgx-20260805.xsd EX-101.SCH 3035
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptgx-20260805_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptgx-20260805_pre.xml EX-101.PRE 22372
66 EXTRACTED XBRL INSTANCE DOCUMENT tm2622272d1_8k_htm.xml XML 3213
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 261243623
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)